Corticosteroids are powerful anti-inflammatory medicines. In ankylosing spondylitis (AS), they can bring rapid symptom relief, but they are not a one-size-fits-all solution. Used thoughtfully, steroids help control flares and targeted inflammation. Used indiscriminately, they expose patients to important risks without changing the underlying disease course.
When steroids are useful in AS
Steroids have a clear role in specific situations:
- Acute flares — short courses of systemic steroids can ease severe pain and stiffness for a limited time.
- Peripheral arthritis — when joints outside the spine are inflamed, steroids (oral or injected) can be effective.
- Local injections — intra-articular or periarticular steroid injections for sacroiliac joints or large peripheral joints often give targeted relief with fewer systemic effects.
- Bridge therapy — steroids can be used briefly while waiting for slower-acting treatments (for example, a biologic) to take effect.
Short-term versus long-term use
It helps to think of steroids in two ways: short-term “bursts” for immediate control, and chronic use for ongoing suppression.
Short-term strategies
- Oral bursts — a brief course of oral corticosteroids (days to a few weeks) to control a flare or severe peripheral inflammation.
- Local injections — steroid injections into a painful joint or the sacroiliac region for focused relief; these often allow reduction of systemic medicines.
- Goal — use the lowest effective dose for the shortest time needed and then reassess.
Long-term use: why it is generally avoided
Chronic systemic corticosteroids are usually not recommended for axial ankylosing spondylitis because long-term use:
- Does not reliably prevent spinal damage or disease progression.
- Increases the risk of serious side effects such as osteoporosis, diabetes, high blood pressure, weight gain, cataracts, and infections.
- Causes adrenal suppression if used for many weeks or months, complicating withdrawal.
▶
Risks and monitoring
If steroids are prescribed, patients and clinicians should monitor and mitigate side effects:
- Bone health — assess baseline bone density, supplement with calcium and vitamin D, and consider bisphosphonates when appropriate.
- Metabolic checks — monitor blood glucose and blood pressure, especially in people with diabetes or hypertension.
- Infection risk — be cautious with live vaccines and watch for signs of infection while on steroids.
- Adrenal suppression — avoid abrupt stopping after prolonged use; taper under medical guidance.
How steroids fit into a comprehensive AS treatment plan
Steroids are one tool among several. Effective long-term management focuses on therapies that control inflammation and reduce structural damage while preserving function.
- NSAIDs — first line for pain and stiffness in many patients.
- Physiotherapy and exercise — essential for posture, mobility, and long-term function.
- Biologic therapies — tumor necrosis factor inhibitors and interleukin-17 inhibitors are effective at controlling axial inflammation and preventing progression in many people with active disease.
- Conventional DMARDs — may help for peripheral joint disease but have limited effect on axial disease.
- Steroid-sparing approach — aim to minimize systemic steroid exposure by optimizing the above options and using local steroid injections when needed.
Practical guidance for people with AS
- Discuss goals with your clinician — ask whether steroids are intended for short-term symptom control or another specific purpose.
- Prefer localized injections for isolated joint pain to reduce systemic exposure.
- Use the lowest effective dose for the shortest possible time.
- Plan for bone protection if any steroid use is expected—ensure adequate calcium and vitamin D and check bone density when indicated.
- Monitor metabolic health during and after steroid courses—blood pressure, weight, and glucose.
- Taper carefully after prolonged courses to avoid adrenal insufficiency; do not stop abruptly without guidance.
- Consider steroid-sparing therapies such as biologics when disease activity requires ongoing control.
Summary
Steroids can be a valuable short-term tool for managing flares and relieving peripheral joint inflammation in ankylosing spondylitis. They should be used at the lowest effective dose for the shortest time, with careful attention to bone health and metabolic monitoring. Chronic systemic steroid therapy is generally avoided for axial disease because it does not reliably change long-term outcomes and exposes patients to significant risks. Integrating steroids into a broader treatment plan that includes NSAIDs, physiotherapy, and disease-modifying or biologic agents offers the best chance of symptom control and preservation of function.
